January 24, 2017
Horizon Discovery expects 2016 revenue up 20%
Horizon Discovery Group expects to see 2016 revenues rise for about 20%, as it expects revenue of at least £24.0 million.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 24, 2017
Quantum Pharma grantes options to its CFO
Quantum Pharma, has granted options over 1,100,000 Ordinary Shares of 10 pence each (‘Ordinary Shares’) with an exercise price of 30 pence, to Gerard Murray, Chief Financial Officer.
January 24, 2017
Nicox to test new eye drug
Nicox, the international ophthalmic R&D company, has provided certain regulatory and clinical updates for NCX 470, its novel nitric oxide…
January 24, 2017
Asit’s Phase II study of dust allergy treatment shows success
Asit biotech has completed Phase IIa double-blind placebo-controlled clinical study in house dust mite-induced rhinoconjunctivitis.
January 24, 2017
Abzena to issue ordinary shares
Abzena has made application to the London Stock Exchange for the admission of 715,772 new ordinary shares of £0.002 each (‘New Ordinary Shares’) to trading on AIM.
January 24, 2017
Short: Van Herk Investments announces 10.07% Shareholding in Ablynx
Van Herk Investments B.V. has become owner of more than 10% of Ablynx as it has crossed the 10% threshold and now…
January 24, 2017
ImmuPharma appoints new adviser
ImmuPharma has appointed Northland Capital Partners as its Nominated Adviser and sole broker with immediate effect. ImmuPharma is a pharmaceutical…
January 23, 2017
Swedish Oasmia targets $16B worth US animal health care market
A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.
January 23, 2017
Stada names new executive board member
STADA Arzneimittel AG has named Dr. Barthold Piening as a full Member of the Executive Board with effect from July 1, 2017.
January 23, 2017
Alliance Pharma reduces net debt, doubles revenue
Alliance Pharma’s revenue for 2016, driven by the acquisition of ex-Sinclair products in December 2015, could be more than double compared to the previous year.